S. S. Tejtel

The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.

Katherine K. Kim, R. DeBiasi, J. Newburger, 2019, Contemporary clinical trials.

Lesion-Specific Congenital Heart Disease Mortality Trends in Children: 1999 to 2017.

S. Morris, J. Salemi, K. Lopez, 2022, Pediatrics.

Sudden death in children with cardiac allograft vasculopathy

W. Dreyer, J. Heinle, A. Cabrera, 2016 .

Decreased Quality of Life in Children With Anomalous Aortic Origin of a Coronary Artery

Katherine E Cutitta, A. Qureshi, C. Noel, 2021, World journal for pediatric & congenital heart surgery.

Cardiovascular sequelae from COVID-19: perspectives from a paediatric cardiac ICU

L. Shekerdemian, J. Lasa, Alexander Alali, 2022, Cardiology in the Young.

Incidence and Outcomes of Kawasaki Shock Syndrome in United States:2004-2014

Hitesh Agrawal, Thomas J. Seery, C. Altman, 2018 .

Comparison of Laboratory and Hemodynamic Time Series Data Across Original, Alpha, and Delta Variants in Patients With Multisystem Inflammatory Syndrome in Children

C. Rusin, A. Annapragada, L. Shekerdemian, 2022, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Multi‐Disciplinary Collaborative Consensus Guidance Statement on the Assessment and Treatment of Post‐Acute Sequelae of SARS‐CoV‐2 Infection (PASC) in Children and Adolescents

J. Silver, S. D. de Ferranti, S. McGrath-Morrow, 2022, PM & R : the journal of injury, function, and rehabilitation.